Atara biotherapeutics reports q2 loss per share $1.14

Atara biotherapeutics announces second quarter 2020 financial results and operational progress.q2 loss per share $1.14.q2 earnings per share estimate $-1.18 -- refinitiv ibes data.
ATRA Ratings Summary
ATRA Quant Ranking